Main Characteristics

SPECIALISATION:

   Exclusively working in lentivirus

CDMO BUSINESS MODEL:

Covering the different phases

CUTTING-EDGE TECHNOLOGIES:

Seal of Excellence from European Commission

SCIENTIFIC EXPERTISE:

Own lentivirus-based technology (Lentisoma)

CUSTOMISED APPROACH TO PROJECTS:

Slots availability in a timely manner

BROAD EXPERTISE AND EXPERIENCE OF OUR TEAM:

Manufacture of lentiviral vectors for CAR-T/TCR and gene therapy clinical trials

THE MOST INNOVATIVE EQUIPMENT AVAILABLE:

  • iCELLis® bioreactor technology
  • Compatible equipment at R&D and GMP suites
  • More than 1600 m2 (17000 ft2) labs

MANUFACTURING PLATFORM DEVELOPMENT:

Increased final yield compared with regular protocols

POTENTIALITY:

Facilities, capability and infrastructure to increase current capacity

INTERNATIONAL COMPANY:

US and European customers

main-charecteristics.jpg

Contact us

Mikeletegi Pasealekua 81, San Sebastián 20009, Gipuzkoa (SPAIN)

JOIN US

linkedinb